1. Home
  2. WFCF vs MNOV Comparison

WFCF vs MNOV Comparison

Compare WFCF & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Where Food Comes From Inc.

WFCF

Where Food Comes From Inc.

N/A

Current Price

$13.24

Market Cap

61.3M

Sector

Technology

ML Signal

N/A

Logo Medicinova Inc

MNOV

Medicinova Inc

HOLD

Current Price

$1.46

Market Cap

66.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
MNOV
Founded
1996
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.3M
66.9M
IPO Year
2006
2004

Fundamental Metrics

Financial Performance
Metric
WFCF
MNOV
Price
$13.24
$1.46
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
3.8K
43.0K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.30
N/A
Revenue
$20,774,416.00
$2,360,807.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$180.00
P/E Ratio
$40.60
N/A
Revenue Growth
16.69
194.15
52 Week Low
$9.69
$1.17
52 Week High
$13.75
$1.96

Technical Indicators

Market Signals
Indicator
WFCF
MNOV
Relative Strength Index (RSI) 55.21 52.50
Support Level $11.79 $1.40
Resistance Level $13.63 $1.60
Average True Range (ATR) 0.45 0.06
MACD -0.05 0.01
Stochastic Oscillator 61.50 58.82

Price Performance

Historical Comparison
WFCF
MNOV

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company conducting both on-site and desk audits to verify that claims being made about livestock, food, other high-value specialty crops and agricultural and aquaculture products are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. It also provides a wide range of professional consulting services. It generates the majority of its revenue from Verification and certification services.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: